Cargando…

Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel

It has been suggested that the benefit of adjuvant chemotherapy (CT) in premenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 negative (HER2−) early breast cancer may be related, at least in part, to CT-induced ovarian function suppression (OFS) in this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arboleda, Bolivar, Bartsch, Rupert, de Azambuja, Evandro, Hamilton, Erika, Harbeck, Nadia, Klemp, Jennifer, Knauer, Michael, Kuemmel, Sherko, Mahtani, Reshma, Schwartzberg, Lee, Villarreal-Garza, Cynthia, Wolff, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Breast Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438910/ https://www.ncbi.nlm.nih.gov/pubmed/35704278 http://dx.doi.org/10.1093/oncolo/oyac101

Ejemplares similares

Breast Implant Illness: An Expert-Panel Discussion on Current Research
por: Kenkel, Jeffrey M, et al.
Publicado: (2021)

Canadian Expert Opinion on Breast Reconstruction Access: Strategies to Optimize Care during COVID-19
por: Isaac, Kathryn V., et al.
Publicado: (2022)

Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer
por: Minarikova, Lenka, et al.
Publicado: (2016)

Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group
por: Baltzer, Pascal, et al.
Publicado: (2019)

Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer
por: Savill, Kristin M Zimmerman, et al.
Publicado: (2023)

I-SPY 2: optimising cancer drug development in the 21st century
por: Bartsch, Rupert, et al.
Publicado: (2016)

Post-mastectomy Breast Reconstruction with Autologous Tissue: Current Methods and Techniques
por: Garza, Ramon, et al.
Publicado: (2021)

Red Breast Syndrome and Acellular Dermal Matrix
por: Podsednik Gardner, Allison, et al.
Publicado: (2023)

Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer cases
por: Koch, Henrik Wethe, et al.
Publicado: (2023)

“Immediate versus delayed autologous breast reconstruction in patients undergoing post‐mastectomy radiation therapy: A paradigm shift”
por: Wu Young, Mimi Y., et al.
Publicado: (2022)

BREAST-Q and Donor Site Comparison in Bilateral Stacked Autologous Breast Reconstruction
por: Haddock, Nicholas T., et al.
Publicado: (2022)

Towards clinical grating-interferometry mammography
por: Arboleda, Carolina, et al.
Publicado: (2019)

Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks
por: Boughey, Judy C., et al.
Publicado: (2016)

Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making
por: Boughey, Judy C., et al.
Publicado: (2016)

Integrative oncology for breast cancer patients: introduction of an expert-based model
por: Dobos, Gustav J, et al.
Publicado: (2012)

Correction to: Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel
Publicado: (2022)

A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial
por: Blackwell, Kimberly, et al.
Publicado: (2016)

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
por: Soliman, Hatem, et al.
Publicado: (2020)

The Deeper the Love, the Deeper the Hate
por: Jin, Wang, et al.
Publicado: (2017)

Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial
por: Diéras, Véronique, et al.
Publicado: (2019)

Duration of Chemotherapy-induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles
por: Navari, Rudolph, et al.
Publicado: (2022)

Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2− Advanced Breast Cancer: Findings From a Multicountry Survey
por: Cardoso, Fatima, et al.
Publicado: (2023)

Prognostic Factors for Overall Survival in Patients with Hormone Receptor‐Positive Advanced Breast Cancer: Analyses From PALOMA‐3
por: Rugo, Hope S., et al.
Publicado: (2021)

Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions
por: Veltman, J., et al.
Publicado: (2008)

What parameters affect pain in core biopsy?
por: Zografos, George C., et al.
Publicado: (2008)

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008)

Value of tissue harmonic imaging (THI) and contrast harmonic imaging (CHI) in detection and characterisation of breast tumours
por: Clevert, D.- A., et al.
Publicado: (2006)

Computer-aided detection in breast MRI: a systematic review and meta-analysis
por: Dorrius, Monique D., et al.
Publicado: (2011)

Using computer-aided detection in mammography as a decision support
por: Samulski, Maurice, et al.
Publicado: (2010)

Stereotactic large-core needle breast biopsy: analysis of pain and discomfort related to the biopsy procedure
por: Hemmer, Judith M., et al.
Publicado: (2007)

Shear wave elastography for breast masses is highly reproducible
por: Cosgrove, David O., et al.
Publicado: (2011)

Increase in perceived case suspiciousness due to local contrast optimisation in digital screening mammography
por: Visser, Roelant, et al.
Publicado: (2011)

The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging
por: Dorrius, M. D., et al.
Publicado: (2011)

MR-guided breast biopsy at 3T: diagnostic yield of large core needle biopsy compared with vacuum-assisted biopsy
por: Meeuwis, Carla, et al.
Publicado: (2011)

Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review
por: Robertson, Clare, et al.
Publicado: (2011)

Value of the BI-RADS classification in MR-Mammography for diagnosis of benign and malignant breast tumors
por: Sohns, Christian, et al.
Publicado: (2011)

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
por: Fangberget, A., et al.
Publicado: (2010)

Breast cancer detection: radiologists’ performance using mammography with and without automated whole-breast ultrasound
por: Kelly, Kevin M., et al.
Publicado: (2010)

The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool
por: Timmers, J. M. H., et al.
Publicado: (2012)

Feasibility of MRI-guided large-core-needle biopsy of suspiscious breast lesions at 3 T
por: Peters, Nicky H. G. M., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0l58c0ua0mjaepj5vnl838g6jb